India marks its fifth $1B drugmaker

Zydus Cadila has joined the $1 billion-turnover club of Indian drugmakers. It was a $400 million company just four years ago, and planned for the ascent to $1 billion. It hopes to reach $3 billion by 2015. Cadila is welcomed to the club by Cipla, Ranbaxy, GSK and Piramal Group. Story